During the past decade, Wojewodzki Szpital Specjalistyczny w Legnicy conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wojewodzki Szpital Specjalistyczny w Legnicy" #1 sponsor was "BeiGene" with 4 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Cyclacel Pharmaceuticals, Inc." with 1 trials sponsored, "Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojewodzki Szpital Specjalistyczny w Legnicy" #1 collaborator was "Centre Hospitalier Universitaire de Besancon" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator, "Ferrer Internacional S.A." with 1 trials as a collaborator, "General University Hospital, Prague" with 1 trials as a collaborator and "Istituto Di Ricerche Farmacologiche Mario Negri" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Wojewodzki Szpital Specjalistyczny w Legnicy" are "Chronic Lymphocytic Leukemia" (3 trials), "Small Lymphocytic Lymphoma" (2 trials), "Acute Myeloid Leukemia" (1 trials), "CLL/SLL" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Wojewodzki Szpital Specjalistyczny w Legnicy" in a lesser frequency.

Most popular intervention types in "Wojewodzki Szpital Specjalistyczny w Legnicy" are "Drug" (13 trials). Other intervention types were less common.

The name of intervention was led by "Zanubrutinib" (3 trials), "Obinutuzumab" (2 trials), "Bendamustine" (1 trials), "CPA" (1 trials) and "Cardiovascular Polypill" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wojewodzki Szpital Specjalistyczny w Legnicy" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Wojewodzki Szpital Specjalistyczny w Legnicy". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Wojewodzki Szpital Specjalistyczny w Legnicy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wojewodzki Szpital Specjalistyczny w Legnicy, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".